Initial Statement of Beneficial Ownership (3)

FORM 3	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES	OMB APPROVAL OMB Number: 3235-0104 Estimated average burden hours per response... 0.5
	Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940

1. Name and Address of Reporting Person * CHIDAMBARAM CHIDAMBARAM ALAGAPPA	2. Date of Event Requiring Statement (MM/DD/YYYY) 5/22/2019	3. Issuer Name and Ticker or Trading Symbol DENTSPLY SIRONA Inc. [XRAY]
(Last)        (First)        (Middle) 13320 BALLANTYNE CORPORATE PLACE	4. Relationship of Reporting Person(s) to Issuer (Check all applicable) _____ Director                            _____ 10% Owner ___ X ___ Officer (give title below)          _____ Other (specify below) SVP, Chief Digital Officer /
(Street) CHARLOTTE, NC 28277        (City)              (State)              (Zip)	5. If Amendment, Date Original Filed (MM/DD/YYYY)	6. Individual or Joint/Group Filing (Check Applicable Line) _ X _ Form filed by One Reporting Person ___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	4534.655   (1)	D

Table II - Derivative Securities Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security (Instr. 4)	2. Date Exercisable and Expiration Date (MM/DD/YYYY)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Buy)	(2)	11/13/2028	Common Stock	2200	$36.71	D
Stock Option (Right to Buy)	(2)	11/13/2028	Common Stock	11600	$36.71	D
Stock Option (Right to Buy)	(3)	3/12/2029	Common Stock	5300	$49.29	D

Explanation of Responses:
(1)	The amount shown represents Restricted Stock Units (RSUs).
(2)	Stock Options vest in annual one-third (1/3) increments over a three-year period ending November 13, 2021.
(3)	Stock Options vest in annual one-third (1/3) increments over a three-year period ending March 12, 2022.

Reporting Owners
Reporting Owner Name / Address	Relationships
	Director	10% Owner	Officer	Other
CHIDAMBARAM CHIDAMBARAM ALAGAPPA 13320 BALLANTYNE CORPORATE PLACE CHARLOTTE, NC 28277			SVP, Chief Digital Officer

Signatures
Dane Baumgardner, Attorney-In-Fact for Chidambaram A. Chidambaram		6/3/2019
** Signature of Reporting Person		Date

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
*	If the form is filed by more than one reporting person, see Instruction 5(b)(v).
**	Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note:	File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.